Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
93%
OVERLAP
BY WEIGHT
224
# OF OVERLAPPING
HOLDINGS
BTEC.L
272
HOLDINGS
100%
ALSO IN BTEE.L
BTEE.L
272
HOLDINGS
100%
ALSO IN BTEC.L
SECTOR DRIFT (BTEC.L minus BTEE.L)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BTEC.L |
Weight in BTEE.L |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 8.7% | 8.7% | 8.7% |
|
GILEAD SCIENCES INC | 8.4% | 8.4% | 8.4% |
|
AMGEN INC | 8.1% | 8.1% | 8.1% |
|
REGENERON PHARMACEUTICALS | 5.8% | 5.8% | 5.8% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 3.6% | 3.6% |
BTEC.L Overweight Relative to BTEE.L
 |
SANOFI-AVENTIS-ADR | 0.0% |
|
AMGEN INC | 0.0% |
|
SAREPTA THERAPEUTICS INC | 0.0% |
 |
AURINIA PHARMACEUTICALS INC. | 0.0% |
|
VERICEL CORPORATION | 0.0% |
|
ALNYLAM PHARMACEUTICALS INC | 0.0% |
|
DYNAVAX TECHNOLOGIES CORP | 0.0% |
|
ACADIA PHARMACEUTICALS INC | 0.0% |
 |
GALAPAGOS NV SPONSORED ADR | 0.0% |
|
LIGAND PHARMACEUTICALS-CL B | 0.0% |
BTEC.L Underweight Relative to BTEE.L
|
SANOFI-AVENTIS-ADR | 0.0% |
|
AMGEN INC | 0.0% |
|
SAREPTA THERAPEUTICS INC | 0.0% |
|
AURINIA PHARMACEUTICALS INC. | 0.0% |
|
VERICEL CORPORATION | 0.0% |
|
ALNYLAM PHARMACEUTICALS INC | 0.0% |
|
DYNAVAX TECHNOLOGIES CORP | 0.0% |
|
ACADIA PHARMACEUTICALS INC | 0.0% |
|
GALAPAGOS NV SPONSORED ADR | 0.0% |
|
LIGAND PHARMACEUTICALS-CL B | 0.0% |